Congressional inaction has led to the expiration of the federal government’s SBIR/STTR program, cutting off a biotechnology ...
BOTHELL, Wash., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces it has received a Small Business Innovation Research (SBIR) Phase I ...
IMVARIA’s development of a new test for more accurate malignancy assessment in chest CTs, building on the success of Fibresolve and advancing healthcare AI innovation IMVARIA Inc., a health tech ...
NIH funding supports a clinical trial of Storii’s telephone-based memoir service that reduces isolation, improves mental health, and connects rural older adults With just a telephone call, we’re ...
Disruptions to SBIR/STTR program leave local life sciences and tech innovators facing tougher paths to commercialization.
BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, has been awarded a $500,000 SBIR Phase I grant (R43AG094410) from the National Institutes of Health (NIH) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback